VODOCAT REPORT AT THE DEPARTMENT OF CARDIOVASCULAR SURGERY - MILITARY CENTRAL HOSPITAL

On May 28, 2026, Medbolide Pharmaceutical JSC attended a scientific seminar hosted by the Department of Cardiothoracic Surgery at Military Central Hospital. The seminar was attended by doctors and nurses from the department and was chaired by the Department Head, Dr. Ngo Tuan Anh.

At the meeting, Medbolide presented and clarified the superior benefits of Torsemide compared to Furosemide, based on scientific evidence from clinical studies. Torsemide is a loop diuretic with a superior mechanism of action compared to older diuretics, such as Furosemide, effectively reducing edema in patients with heart failure, kidney failure, and cirrhosis. Torsemide improves cardiac function and reduces the risk of death from heart failure. This is a product currently being used by doctors in the department under the brand name VODOCAT 5 (active ingredient: Torsemide 5 mg).

The presentation drew significant interest and positive feedback from the doctors regarding the VODOCAT 5 product.

At the conclusion of the session, the company expressed its gratitude and hope to continue partnering with the hospital in providing effective solutions to enhance the quality of patient care. Medbolide Pharmaceutical JSC is proud to be a trusted partner of Military Central Hospital in supplying high-quality, effective medical products that contribute to the healthcare of the people.